Skip to content
memoinOncology Logo memoinOncology Logo memoinOncology Logo
  • CONGRESS REPORTS
    • Solid Tumors
      • ASCO
      • EANM
      • ESMO
      • ESMO IO
      • NANETS
    • Hematology
      • ASH
      • EHA
      • ESH CLL
      • ISHL
      • iwWM
    • Lung Cancer
      • ASCO
      • CSCO
      • ECC
      • ELCC
      • ESMO
      • ESMO Asia
      • WCLC
  • MEDICAL EDUCATION
    • Clinical Trials
    • Preceptorship reports
    • Articles
  • COLLABORATIONS
    • CSCO
    • LACOG
    • SEO
    • SSO
  • SUPPORTER
    • Boehringer Ingelheim in Oncology
    • BeiGene
    • ITM
  • MORE…
    • ABOUT US
    • LINKS
    • CALENDAR
    • VIDEOS

J-AXEL: nab-paclitaxel at least equal to docetaxel in pretreated NSCLC

J-AXEL: nab-paclitaxel at least equal to docetax

Read More

Nivolumab as a new option in patients with relapsed malignant mesothelioma

Nivolumab as a new option in patients with relap

Read More

Interview: Lung cancer screening: hurdles in daily routine and in the research laboratory

Interview: Lung cancer screening: hurdles in daily rou

Read More

Immunotherapy: combination regimens and new data on the significance of mutations

Immunotherapy: combination regimens and new data

Read More

What is new in SCLC?

What is new in SCLC? Lurbinectedin plus irin

Read More

Interview: Antibody-drug conjugates: the age of almost unlimited possibilities has just begun

Interview: Antibody-drug conjugates: the age of

Read More

Specific treatment approaches in the EGFR-mutated setting

Specific treatment approaches in the EGFR-mutate

Read More

KRAS, HER2 & ALK: targeted options and sequencing issues

KRAS, HER2 & ALK: targeted options and seque

Read More

Pushing the bounds in early-stage lung cancer

Pushing the bounds in early-stage lung cancer

Read More

Combinational immunotherapy of nivolumab and ipilimumab prolongs survival in comparison to standard chemotherapy in malignant pleural mesothelioma

Combinational immunotherapy of nivolumab and ipi

Read More
12Next

Sponsors:
This website is intended only for healthcare professionals outside the US, the UK, and Australia   |   This website is supported by an unrestricted medical education grant from BeiGene, Boehringer Ingelheim and ITM
© Copyright 2012 -  memoinOncology BY SPRINGER-VERLAG GmbH   |   Projekt: infill healthcare communication GmbH.   |   Alle Rechte vorbehalten.   |   Die Nutzung der Inhalte ist ausschließlich für den privaten Gebrauch bestimmt. Die über den persönlichen Gebrauch hinausgehende Vervielfältigung und Verbreitung ist nicht gestattet.
Impressum   |   Datenschutzerklärung   |   AGB   |   Kontakt   |   Cookie Einstellungen

Resize font
Contrast
Accessibility by WAH